Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy

Patients sometimes discontinue the use of expensive oral anti-cancer drug (OACD) or biological disease-modifying anti-rheumatic drug (bDMARD) therapies early, leading to medication waste if the patient has not used all dispensed medication.

Source: Research in Social and Administrative Pharmacy - March 26, 2018 Category: Pharmaceuticals Authors: C.L. Bekker, E.J. Melis, A.C.G. Egberts, M.L. Bouvy, H. Gardarsdottir, B.J.F. van den Bemt Source Type: research